{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:49:31Z","timestamp":1775252971056,"version":"3.50.1"},"reference-count":118,"publisher":"National Institute for Health and Care Research","issue":"56","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["08\/68\/01"],"award-info":[{"award-number":["08\/68\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Despite a recent decline in the annual incidence of tuberculosis (TB) in the UK, rates remain higher than in most Western European countries. The detection and treatment of latent TB infection (LTBI) is an essential component of the UK TB control programme.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To assess the prognostic value and cost-effectiveness of the current two interferon gamma release assays (IGRAs) compared with the standard tuberculin skin test (TST) for predicting active TB among untreated individuals at increased risk of TB: (1) contacts of active TB cases and (2) new entrants to the UK from high-TB-burden countries.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A prospective cohort study and economic analysis.<\/jats:p>\n <\/jats:sec>\n \n Participants and setting<\/jats:title>\n Participants were recruited in TB clinics, general practices and community settings. Contacts of active TB cases and migrants who were born in high-TB-burden countries arriving in the UK were eligible to take part if they were aged \u2265\u200916 years.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Outcomes include incidence rate ratios comparing the incidence of active TB in those participants with a positive test result and those with a negative test result for each assay, and combination of tests and the cost per quality-adjusted life-year (QALY) for each screening strategy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 10,045 participants were recruited between May 2010 and July 2015. Among 9610 evaluable participants, 97 (1.0%) developed active TB. For the primary analysis, all test data were available for 6380 participants, with 77 participants developing active TB. A positive result for TST\n a<\/jats:sup>\n (positive if induration is \u2265\u20095\u2009mm) was a significantly poorer predictor of progression to active TB than a positive result for any of the other tests. Compared with TST\n b<\/jats:sup>\n [positive if induration is \u2265\u20096\u2009mm without prior bacillus Calmette\u2013Gu\u00e9rin (BCG) alone, T-SPOT\n \u00ae<\/jats:sup>\n .TB (Oxford Immunotec Ltd, Oxford, UK), TST\n a<\/jats:sup>\n \u2009+\u2009T-SPOT.TB, TST\n a<\/jats:sup>\n \u2009+\u2009IGRA and the three combination strategies including TST\n b<\/jats:sup>\n were significantly superior predictors of progression. Compared with the T-SPOT.TB test alone, TST\n a<\/jats:sup>\n \u2009+\u2009T-SPOT.TB, TST\n b<\/jats:sup>\n \u2009+\u2009QuantiFERON\n \u00ae<\/jats:sup>\n TB Gold In-Tube (QFT-GIT; QIAGEN GmbH, Hilden, Germany) and TST\n b<\/jats:sup>\n \u2009+\u2009IGRA were significantly superior predictors of progression and, compared with QFT-GIT alone, T-SPOT.TB, TST\n a<\/jats:sup>\n \u2009+\u2009T-SPOT.TB, TST\n a<\/jats:sup>\n \u2009+\u2009QFT-GIT, TST\n a<\/jats:sup>\n \u2009+\u2009IGRA, TST\n b<\/jats:sup>\n \u2009+\u2009T-SPOT.TB, TST\n b<\/jats:sup>\n \u2009+\u2009QFT-GIT and TST\n b<\/jats:sup>\n \u2009+\u2009IGRA were significantly superior predictors of progression. When evaluating the negative predictive performance of tests and strategies, negative results for TST\n a<\/jats:sup>\n \u2009+\u2009QFT-GIT were significantly poorer predictors of non-progression than negative results for TST\n a<\/jats:sup>\n , T-SPOT.TB and TST\n a<\/jats:sup>\n \u2009+\u2009IGRA. The most cost-effective LTBI testing strategies are the dual-testing strategies. The cost and QALY differences between the LTBI testing strategies were small; in particular, QFT-GIT, TST\n b<\/jats:sup>\n \u2009+\u2009T-SPOT.TB and TST\n b<\/jats:sup>\n \u2009+\u2009QFT-GIT had very similar incremental net benefit estimates.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n This study found modest differences between tests, or combinations of tests, in identifying individuals who would go on to develop active TB. However, a two-step approach that combined TST\n b<\/jats:sup>\n with an IGRA was the most cost-effective testing option.\n <\/jats:p>\n <\/jats:sec>\n \n Implications for practice and future research<\/jats:title>\n \n The two-step TST\n b<\/jats:sup>\n strategy, which stratified the TST by prior BCG vaccination followed by an IGRA, was the most cost-effective approach. The limited ability of current tests to predict who will progress limits the clinical utility of tests. The implications of these results for the NHS England\/Public Health England national TB screening programme for migrants should be investigated.\n <\/jats:p>\n <\/jats:sec>\n \n Study registration<\/jats:title>\n This study is registered as NCT01162265.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n The National Institute for Health Research Health Technology Assessment programme.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta22560","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T05:22:53Z","timestamp":1539840173000},"page":"1-96","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study"],"prefix":"10.3310","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-1430","authenticated-orcid":true,"given":"Ibrahim","family":"Abubakar","sequence":"first","affiliation":[{"name":"Institute for Global Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2396-246X","authenticated-orcid":true,"given":"Ajit","family":"Lalvani","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-4990","authenticated-orcid":true,"given":"Jo","family":"Southern","sequence":"additional","affiliation":[{"name":"National Infection Service, Public Health England, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-4497","authenticated-orcid":true,"given":"Alice","family":"Sitch","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8544-7685","authenticated-orcid":true,"given":"Charlotte","family":"Jackson","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1724-3485","authenticated-orcid":true,"given":"Oluchukwu","family":"Onyimadu","sequence":"additional","affiliation":[{"name":"Southampton Health Technology Assessment Centre, University of Southampton, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-4448","authenticated-orcid":true,"given":"Marc","family":"Lipman","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-1971","authenticated-orcid":true,"given":"Jonathan J","family":"Deeks","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-8694","authenticated-orcid":true,"given":"Chris","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Blizard Institute, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7092-8547","authenticated-orcid":true,"given":"Graham","family":"Bothamley","sequence":"additional","affiliation":[{"name":"Homerton University Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-4688","authenticated-orcid":true,"given":"Onn Min","family":"Kon","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-6232","authenticated-orcid":true,"given":"Andrew","family":"Hayward","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Health Care, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-1624","authenticated-orcid":true,"given":"Joanne","family":"Lord","sequence":"additional","affiliation":[{"name":"Southampton Health Technology Assessment Centre, University of Southampton, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-2490","authenticated-orcid":true,"given":"Francis","family":"Drobniewski","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6221","published-online":{"date-parts":[[2018,10]]},"reference":[{"key":"key20181016120613208_ref1-bib1","volume-title":"Global Tuberculosis Report 2016","author":"World Health Organization","year":"2016"},{"key":"key20181016120613208_ref1-bib2","volume-title":"Tuberculosis in England: Annual Report","author":"Public Health England","year":"2016"},{"key":"key20181016120613208_ref1-bib3","volume-title":"Collaborative Tuberculosis Strategy for England: 2015 to 2020","author":"Public Health England","year":"2015"},{"key":"key20181016120613208_ref1-bib4","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLOS Med"},{"key":"key20181016120613208_ref1-bib5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"key20181016120613208_ref1-bib6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"key20181016120613208_ref1-bib7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/thoraxjnl-2011-200956","article-title":"Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk","volume":"68","author":"Haldar","year":"2013","journal-title":"Thorax"},{"key":"key20181016120613208_ref1-bib8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1378\/chest.08-2048","article-title":"Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-SPOT.TB test in contact investigations for tuberculosis","volume":"135","author":"Diel","year":"2009","journal-title":"Chest"},{"key":"key20181016120613208_ref1-bib9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/infdis\/jit418","article-title":"Reversion and conversion of interferon-\u03b3 release assay results in HIV-1-infected individuals","volume":"209","author":"Aichelburg","year":"2014","journal-title":"J Infect Dis"},{"key":"key20181016120613208_ref1-bib10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1164\/rccm.201502-0232OC","article-title":"Risk assessment of tuberculosis in contacts by IFN-\u03b3 release assays. A Tuberculosis Network European Trials Group study","volume":"191","author":"Zellweger","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key20181016120613208_ref1-bib12","volume-title":"Guidelines on the Management of Latent Tuberculosis Infection","author":"World Health Organization","year":"2015"},{"key":"key20181016120613208_ref1-bib13","volume-title":"Latent TB Infection (LTBI): Testing and Treatment","author":"Public Health England","year":"2016"},{"key":"key20181016120613208_ref1-bib14","volume-title":"Tuberculosis: NICE Guidelines","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"key20181016120613208_ref1-bib15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"key20181016120613208_ref1-bib16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-\u03b3 release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key20181016120613208_ref1-bib17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1089\/AID.2011.0360","article-title":"Predictive value of interferon-\u03b3 ELISPOT assay in HIV 1-infected patients in an intermediate tuberculosis-endemic area","volume":"28","author":"Kim","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key20181016120613208_ref1-bib18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5588\/ijtld.11.0416","article-title":"Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA","volume":"16","author":"Lange","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib19","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1600-6143.2011.03625.x","article-title":"A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients","volume":"11","author":"Kim","year":"2011","journal-title":"Am J Transplant"},{"key":"key20181016120613208_ref1-bib20","doi-asserted-by":"publisher","first-page":"e43520","DOI":"10.1371\/journal.pone.0043520","article-title":"Observational study of QuantiFERON\u00ae-TB Gold In-Tube assay in tuberculosis contacts in a low incidence area","volume":"7","author":"Bergot","year":"2012","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20181016120613208_ref1-bib22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","article-title":"Interferon-\u03b3 ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial","volume":"187","author":"Adetifa","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1513\/AnnalsATS.201408-394OC","article-title":"Predicting the development of tuberculosis with the tuberculin skin test and QuantiFERON testing","volume":"12","author":"Altet","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"key20181016120613208_ref1-bib24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB Gold In-Tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib25","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1017\/S0950268814002386","article-title":"Vitamin D status and incidence of tuberculosis infection conversion in contacts of pulmonary tuberculosis patients: a prospective cohort study","volume":"143","author":"Arnedo-Pena","year":"2015","journal-title":"Epidemiol Infect"},{"key":"key20181016120613208_ref1-bib26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.5588\/ijtld.15.0872","article-title":"M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts","volume":"20","author":"Balcells","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12879-014-0654-5","article-title":"QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study","volume":"14","author":"Belay","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key20181016120613208_ref1-bib28","doi-asserted-by":"publisher","first-page":"e107245","DOI":"10.1371\/journal.pone.0107245","article-title":"QuantiFERON-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\u00f4te d\u2019Ivoire, West Africa","volume":"9","author":"Danel","year":"2014","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/QAI.0000000000000109","article-title":"Latent tuberculosis screening using interferon-gamma release assays in an Australian HIV-infected cohort: is routine testing worthwhile?","volume":"66","author":"Doyle","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key20181016120613208_ref1-bib30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.lungcan.2014.07.001","article-title":"Latent TB infection in newly diagnosed lung cancer patients \u2013 a multicenter prospective observational study","volume":"85","author":"Fan","year":"2014","journal-title":"Lung Cancer"},{"key":"key20181016120613208_ref1-bib31","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1183\/09031936.00187112","article-title":"How can we achieve better prevention of progression to tuberculosis among contacts?","volume":"42","author":"Geis","year":"2013","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib32","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.33321\/cdi.2015.39.16","article-title":"Supplemental use of an interferon-gamma release assay in a state-wide tuberculosis contact tracing program in Victoria: a six-year review","volume":"39","author":"Goebel","year":"2015","journal-title":"Commun Dis Intell Q Rep"},{"key":"key20181016120613208_ref1-bib33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/00365548.2014.987813","article-title":"Role of QuantiFERON(\u00ae)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit","volume":"47","author":"Gonz\u015blez-Moreno","year":"2015","journal-title":"Infect Dis"},{"key":"key20181016120613208_ref1-bib34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1136\/thoraxjnl-2015-208228","article-title":"Prognostic value of interferon-\u03b3 release assays, a population-based study from a TB low-incidence country","volume":"71","author":"Hermansen","year":"2016","journal-title":"Thorax"},{"key":"key20181016120613208_ref1-bib35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.transproceed.2013.11.108","article-title":"Utility of QuantiFERON-TB assay for prediction of tuberculosis development in kidney transplant patients in an intermediate-tuberculosis-burden country: lack of evidence for enhanced prediction for short-term tuberculosis development","volume":"46","author":"Jeong","year":"2014","journal-title":"Transplant Proc"},{"key":"key20181016120613208_ref1-bib36","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.5588\/ijtld.13.0239","article-title":"Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women","volume":"17","author":"Jonnalagadda","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.5588\/ijtld.13.0644","article-title":"The \u2018either test positive\u2019 strategy for latent tuberculous infection before anti-tumour necrosis factor treatment","volume":"18","author":"Jung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib38","doi-asserted-by":"publisher","first-page":"e0141033","DOI":"10.1371\/journal.pone.0141033","article-title":"The significance of sensitive interferon gamma release assays for diagnosis of latent tuberculosis infection in patients receiving tumor necrosis factor-\u03b1 antagonist therapy","volume":"10","author":"Jung","year":"2015","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib39","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.3748\/wjg.v21.i11.3308","article-title":"Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents","volume":"21","author":"Kim","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20181016120613208_ref1-bib40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3109\/00365548.2014.938691","article-title":"Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay","volume":"46","author":"Kim","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"key20181016120613208_ref1-bib41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.5588\/ijtld.14.0636","article-title":"Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea","volume":"19","author":"Kim","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/1756-185X.12515","article-title":"Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents","volume":"18","author":"Kim","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"key20181016120613208_ref1-bib43","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.transproceed.2013.08.059","article-title":"Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation","volume":"45","author":"Kim","year":"2013","journal-title":"Transplant Proc"},{"key":"key20181016120613208_ref1-bib44","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-\u03b3-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key20181016120613208_ref1-bib45","first-page":"111","article-title":"QuantiFERON TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents","volume":"31","author":"Klein","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"key20181016120613208_ref1-bib46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3109\/00365548.2014.927955","article-title":"Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland","volume":"46","author":"Kruczak","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"key20181016120613208_ref1-bib47","doi-asserted-by":"publisher","first-page":"e0119260","DOI":"10.1371\/journal.pone.0119260","article-title":"QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment","volume":"10","author":"Lee","year":"2015","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib48","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00408-013-9481-5","article-title":"Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea","volume":"191","author":"Lee","year":"2013","journal-title":"Lung"},{"key":"key20181016120613208_ref1-bib49","doi-asserted-by":"publisher","first-page":"e0135801","DOI":"10.1371\/journal.pone.0135801","article-title":"A clinical algorithm to identify HIV patients at high risk for incident active tuberculosis: a prospective 5-year cohort study","volume":"10","author":"Lee","year":"2015","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jinf.2014.02.019","article-title":"A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients","volume":"69","author":"Lee","year":"2014","journal-title":"J Infect"},{"key":"key20181016120613208_ref1-bib51","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/resp.12805","article-title":"Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong","volume":"21","author":"Leung","year":"2016","journal-title":"Respirology"},{"key":"key20181016120613208_ref1-bib52","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/resp.12483","article-title":"T-SPOT.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts","volume":"20","author":"Leung","year":"2015","journal-title":"Respirology"},{"key":"key20181016120613208_ref1-bib53","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/INF.0000000000000874","article-title":"Risk of disease after isoniazid preventive therapy for Mycobacterium tuberculosis exposure in young HIV-uninfected children","volume":"34","author":"Luabeya","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key20181016120613208_ref1-bib54","doi-asserted-by":"publisher","first-page":"e59652","DOI":"10.1371\/journal.pone.0059652","article-title":"TB incidence in an adolescent cohort in South Africa","volume":"8","author":"Mahomed","year":"2013","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib55","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1164\/rccm.201406-1165OC","article-title":"Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting","volume":"191","author":"Mandalakas","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib56","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1164\/rccm.201508-1595OC","article-title":"Quantitative IFN-\u03b3 and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women","volume":"193","author":"Mathad","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1399-3062.2012.00765.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation","volume":"15","author":"Moon","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"key20181016120613208_ref1-bib58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/ciu796","article-title":"Prevention of anti-TNF \u2013 associated Tuberculosis study team of Bellvitge University Hospital. Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study","volume":"60","author":"Mu\u00f1oz","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key20181016120613208_ref1-bib59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6673-8-1","article-title":"Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-\u03b3 release assay (IGRA) in Portuguese healthcare workers","volume":"8","author":"Nienhaus","year":"2013","journal-title":"J Occup Med Toxicol"},{"key":"key20181016120613208_ref1-bib60","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial","volume":"384","author":"Rangaka","year":"2014","journal-title":"Lancet"},{"key":"key20181016120613208_ref1-bib61","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4103\/1817-1737.180023","article-title":"Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients","volume":"11","author":"Seyhan","year":"2016","journal-title":"Ann Thorac Med"},{"key":"key20181016120613208_ref1-bib63","first-page":"26","article-title":"Concordance of the tuberculin skin test and T-SPOT(\u00ae).TB test results in kidney transplant candidates","volume":"19","author":"Sherkat","year":"2014","journal-title":"J Res Med Sci"},{"key":"key20181016120613208_ref1-bib64","doi-asserted-by":"publisher","first-page":"e3813","DOI":"10.1097\/MD.0000000000003813","article-title":"Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay","volume":"95","author":"Shu","year":"2016","journal-title":"Medicine"},{"key":"key20181016120613208_ref1-bib65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1183\/09031936.00170913","article-title":"6-year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in Denmark","volume":"44","author":"Soborg","year":"2014","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib66","doi-asserted-by":"publisher","first-page":"e100267","DOI":"10.1371\/journal.pone.0100267","article-title":"Comparison of the tuberculin skin test and interferon gamma release assay for the screening of tuberculosis in adolescents in close contact with tuberculosis TB patients","volume":"9","author":"Song","year":"2014","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib67","doi-asserted-by":"publisher","first-page":"ofu047","DOI":"10.1093\/ofid\/ofu047","article-title":"Estimated prevalence of tuberculosis infection among a New York City clinic population using interferon-gamma release assays","volume":"1","author":"Stennis","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"key20181016120613208_ref1-bib68","doi-asserted-by":"publisher","first-page":"e0125260","DOI":"10.1371\/journal.pone.0125260","article-title":"Risk of active tuberculosis in HIV-infected patients in Taiwan with free access to HIV care and a positive T-SPOT.TB test","volume":"10","author":"Sun","year":"2015","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib69","first-page":"22","article-title":"Use of interferon gamma release assay to assess latent tuberculosis infection among healthcare workers in Hong Kong","volume":"21","author":"Tsang","year":"2015","journal-title":"Hong Kong Med J"},{"key":"key20181016120613208_ref1-bib70","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/ggi.12416","article-title":"QuantiFERON TB-Gold conversion can predict active tuberculosis development in elderly nursing home residents","volume":"15","author":"Tsou","year":"2015","journal-title":"Geriatr Gerontol Int"},{"key":"key20181016120613208_ref1-bib71","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.dld.2014.07.006","article-title":"Screening prior to biological therapy in Crohn\u2019s disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study","volume":"46","author":"van der Have","year":"2014","journal-title":"Dig Liver Dis"},{"key":"key20181016120613208_ref1-bib72","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/1471-2334-14-383","article-title":"Agreement between QuantiFERON\u00ae-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts","volume":"14","author":"Verhagen","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key20181016120613208_ref1-bib73","doi-asserted-by":"publisher","first-page":"e58202","DOI":"10.1371\/journal.pone.0058202","article-title":"Prevalence and incidence of latent tuberculosis infection in Georgian healthcare workers","volume":"8","author":"Whitaker","year":"2013","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib74","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1183\/09031936.00125714","article-title":"An evaluation of the use of a negative interferon-\u03b3 release assay for tuberculosis screening before TNF antagonist therapy","volume":"44","author":"Woodfield","year":"2014","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib75","doi-asserted-by":"publisher","first-page":"e73069","DOI":"10.1371\/journal.pone.0073069","article-title":"Strategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated population","volume":"8","author":"Yang","year":"2013","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib76","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/23744235.2015.1026935","article-title":"Use of the QuantiFERON\u00ae-TB Gold In Tube test for screening TB contacts and predictive value for active TB","volume":"47","author":"Yoshiyama","year":"2015","journal-title":"Infect Dis"},{"key":"key20181016120613208_ref1-bib77","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3760\/cma.j.issn.0366-6999.20130355","article-title":"A prospective longitudinal study evaluating a T-cell-based assay for latent tuberculosis infection in health-care workers in a general hospital in Beijing","volume":"126","author":"Zhang","year":"2013","journal-title":"Chin Med J"},{"key":"key20181016120613208_ref1-bib78","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12889-016-3519-6","article-title":"Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays","volume":"16","author":"Blount","year":"2016","journal-title":"BMC Public Health"},{"key":"key20181016120613208_ref1-bib79","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update","volume":"183","author":"Diel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib80","first-page":"1209","article-title":"Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers","volume":"14","author":"Harstad","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib81","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik","year":"2010","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s15010-008-8082-3","article-title":"High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test","volume":"37","author":"Lee","year":"2009","journal-title":"Infection"},{"key":"key20181016120613208_ref1-bib83","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1164\/rccm.200912-1875OC","article-title":"T-SPOT.TB outperforms tuberculin skin test in predicting tuberculosis disease","volume":"182","author":"Leung","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib84","doi-asserted-by":"publisher","first-page":"e17984","DOI":"10.1371\/journal.pone.0017984","article-title":"The tuberculin skin test versus QuantiFERON TB Gold\u00ae in predicting tuberculosis disease in an adolescent cohort study in South Africa","volume":"6","author":"Mahomed","year":"2011","journal-title":"PLOS ONE"},{"key":"key20181016120613208_ref1-bib85","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control","author":"National Collaborating Centre for Chronic Conditions","year":"2006"},{"key":"key20181016120613208_ref1-bib86","volume-title":"Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control","author":"National Institute for Health and Care Excellence","year":"2011"},{"key":"key20181016120613208_ref1-bib87","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1472-6963-11-247","article-title":"Systematic review of cost and cost-effectiveness of different TB-screening strategies","volume":"11","author":"Nienhaus","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"key20181016120613208_ref1-bib88","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"de Perio","year":"2009","journal-title":"Arch Intern Med"},{"key":"key20181016120613208_ref1-bib89","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib90","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"Diel","year":"2007","journal-title":"Chest"},{"key":"key20181016120613208_ref1-bib91","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"Diel","year":"2007","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib92","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","author":"Kowada","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"key20181016120613208_ref1-bib93","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON(R)-TB Gold, in screening tuberculosis contacts","volume":"12","author":"Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib94","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis","volume":"11","author":"Oxlade","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib95","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"key20181016120613208_ref1-bib96","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1183\/09031936.06.00011806","article-title":"Cost-optimisation of screening for latent tuberculosis in close contacts","volume":"28","author":"Diel","year":"2006","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib97","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.rmed.2009.07.008","article-title":"Enhanced cost\u2013benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany","volume":"103","author":"Diel","year":"2009","journal-title":"Respir Med"},{"key":"key20181016120613208_ref1-bib98","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00408-009-9182-2","article-title":"The QuantiFERON-TB-Gold assay for tuberculosis screening in healthcare workers: a cost-comparison analysis","volume":"187","author":"Fox","year":"2009","journal-title":"Lung"},{"key":"key20181016120613208_ref1-bib99","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/thx.2009.119677","article-title":"Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries","volume":"65","author":"Hardy","year":"2010","journal-title":"Thorax"},{"key":"key20181016120613208_ref1-bib100","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/09031936.06.00005906","article-title":"Direct costs of three models for the screening of latent tuberculosis infection","volume":"28","author":"Wrighton-Smith","year":"2006","journal-title":"Eur Respir J"},{"key":"key20181016120613208_ref1-bib101","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon \u03b3 release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2012","journal-title":"Thorax"},{"issue":"38","key":"key20181016120613208_ref1-bib102","doi-asserted-by":"publisher","DOI":"10.3310\/hta20380","article-title":"Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation","volume":"20","author":"Auguste","year":"2016","journal-title":"Health Technol Assess"},{"key":"key20181016120613208_ref1-bib103","volume-title":"Immunisation Against Infectious Disease","author":"Department of Health and Social Care","year":"2013"},{"key":"key20181016120613208_ref1-bib104","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis","volume":"177","author":"Diel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key20181016120613208_ref1-bib105","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The Statistical Evaluation of Medical Tests for Classification and Prediction","author":"Pepe","year":"2003"},{"key":"key20181016120613208_ref1-bib106","volume-title":"QuantiFERON\u00ae-TB Gold (QFT\u00ae) ELISA Package Insert","author":"QIAGEN","year":"2016"},{"key":"key20181016120613208_ref1-bib107","volume-title":"Interpreting Tuberculosis Test Results with the T-SPOT.TB Test","author":"Oxford Immunotec","year":"2017"},{"key":"key20181016120613208_ref1-bib108","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12955-015-0250-4","article-title":"Health-related quality of life and tuberculosis: a longitudinal cohort study","volume":"13","author":"Bauer","year":"2015","journal-title":"Health Qual Life Outcomes"},{"key":"key20181016120613208_ref1-bib109","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/thoraxjnl-2014-206480","article-title":"The prospective evaluation of the TB strain typing service in England: a mixed methods study","volume":"71","author":"Mears","year":"2016","journal-title":"Thorax"},{"key":"key20181016120613208_ref1-bib110","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"key":"key20181016120613208_ref1-bib111","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"key20181016120613208_ref1-bib112","first-page":"308","article-title":"Estimating tuberculosis case mortality in England and Wales, 2001\u20132002","volume":"12","author":"Crofts","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib113","first-page":"296","article-title":"Health status of UK patients with active tuberculosis","volume":"14","author":"Kruijshaar","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"key20181016120613208_ref1-bib114","volume-title":"National Life Tables, United Kingdom: 2012\u20132014","author":"Office for National Statistics (ONS)","year":"2015"},{"key":"key20181016120613208_ref1-bib115","volume-title":"NHS Reference Costs","author":"Department of Health and Social Care (DHSC)","year":"2014"},{"key":"key20181016120613208_ref1-bib116","volume-title":"Tuberculosis in England: Annual Report","author":"Public Health England","year":"2015"},{"key":"key20181016120613208_ref1-bib117","volume-title":"Latent TB Infection: Updated and Consolidated Guidelines for Programmatic Management","author":"World Health Organization (WHO)","year":"2018"},{"key":"key20181016120613208_ref1-bib118","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB Gold In-Tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta22560\/hta22560.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2003423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta22560\/hta22560.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2021426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:34:53Z","timestamp":1775248493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta22560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":118,"journal-issue":{"issue":"56","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["10.3310\/hta22560"],"URL":"https:\/\/doi.org\/10.3310\/hta22560","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}